Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Augmented Reality Training for Amblyopia After Congenital Cataract Surgery

NCT: NCT07693790 · NOT_YET_RECRUITING

NCT IDNCT07693790
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2028-01
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University (OTHER)
First posted
Last updated

Brief Summary

This study will evaluate whether augmented reality training is effective and safe for treating unilateral amblyopia after congenital cataract surgery in children. Children aged 5 to 12 years with unilateral amblyopia after congenital cataract surgery will be enrolled from three eye hospitals in China. Participants will be randomly assigned to one of two groups. One group will receive augmented reality amblyopia training for 2 hours per day for 4 months. The other group will receive conventional patching of the fellow eye for 4 hours per day for 4 months. The main outcome is the change in best-corrected visual acuity of the amblyopic eye after 4 months of treatment. The study will also evaluate contrast sensitivity, binocular visual function, stereoacuity, vision-related symptoms, quality of life, and adverse events.

Frequently Asked Questions

What is Augmented Reality Training for Amblyopia After Congenital Cataract Surgery?

Augmented Reality Training for Amblyopia After Congenital Cataract Surgery is a clinical trial registered under NCT07693790. Current status: NOT_YET_RECRUITING.

What is the status of NCT07693790?

The current status of NCT07693790 (Augmented Reality Training for Amblyopia After Congenital Cataract Surgery) is: NOT_YET_RECRUITING.

When did Augmented Reality Training for Amblyopia After Congenital Cataract Surgery start?

Augmented Reality Training for Amblyopia After Congenital Cataract Surgery started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.